Bempedoic Acid in Secondary Prevention

• Idine Mousavi,
• Vijay Nambi,
• Layla A. Abushamat,
• Sadeer G. Al-Kindi,
• Michael D. Shapiro,
• Laurence Sperling,
• Salim S. Virani,
• Abdul Mannan Khan Minhas

Affiliations

Idine Mousavi

Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Corresponding author at: 1 Baylor Plaza, Houston, TX 77030, USA.

Vijay Nambi

Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Division of Atherosclerosis and Vascular Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas

Layla A. Abushamat

Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Division of Atherosclerosis and Vascular Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, USA

Sadeer G. Al-Kindi

Department of Cardiology, Houston Methodist Hospital, TX, USA

Michael D. Shapiro

Section on Cardiovascular Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA

Laurence Sperling

Division of Cardiology, Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, Atlanta, GA, USA

Salim S. Virani

Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Aga Khan University, Karachi, Pakistan; Baylor College of Medicine and Texas Heart Institute, Houston, TX, USA

Abdul Mannan Khan Minhas

Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Division of Atherosclerosis and Vascular Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, USA